S2-E29.2 - Previewing Digital ILC 2021 -- Part 1 -- Interests and Issues
Send us Fan Mail EASL Scientific Committee member Luca Valenti joins the Surfers to discuss some of the issues that will be discussed at Digital ILC 2021. After Luca and Stephen Harrison discuss what ...
5 Kesä 202112min
S2-E29.1 - Previewing Digital ILC 2021 -- Part 1 -- Meeting Overview
Send us Fan Mail Stephen Harrison and EASL Scientific Committee member Luca Valenti Preview Highlights of the Digital ILC 2021. Luca and Stephen discuss what each of them consider highlights of this m...
5 Kesä 202112min
S2-E29 - Previewing Digital ILC 2021 -- Part 1
Send us Fan Mail EASL Scientific Organizing Committee member Prof. Luca Valenti joins the Surfers to discuss some of the major NAFLD-related topics we will learn more about at Digital ILC 2021. This e...
3 Kesä 202142min
S2-E27.2 - A Deeper Look At International NASH Day 2021 -- Activities, Future Plans, And Global Liver Institute Growth
Send us Fan Mail Global Liver Institute President and CEO Donna Cryer joins the Surfers to discuss International NASH Day 2021. This conversation takes a deeper look at NASH Day and also Global Liver ...
29 Touko 202120min
S2-E27.1 - previewing International nASH day 2021 -- overview of events
Send us Fan Mail Global Liver Institute President and CEO Donna Cryer joins the Surfers to discuss International NASH Day 2021. This conversation provides and overview of the day's event. The 4th annu...
29 Touko 202114min
S2 - E28 - SPECIAL EPISODE: What Can We Learn The Aldafermin Discontinuation In F2/F3 NASH?
Send us Fan Mail Roger Green narrates a series of interviews, conversations and viewpoints about NGM Biopharmaceuticals discontinuing its F2/F3 aldafermin program The SurfingNASH team weaves interview...
27 Touko 202125min
S2-E27 - Previewing International NASH Day -- a growing Day of Global Education and Organizing
Send us Fan Mail Global Liver Institute President and CEO Donna Cryer joins the Surfers to discuss International NASH Day 2021. Last year's IND had 100+ participants. This year will be bigger! Learn w...
27 Touko 202138min
S2-E26.3 - How much will real-life NASH treatment decisions depend on the specialty of the prescriber?
Send us Fan Mail azen Noureddin returns to discuss the roles different drugs and drug classes will play in NASH therapy after current Phase 2b and Phase 3 candidates have been approved. This conversat...
23 Touko 202118min
